Moderna, Inc. vs Paycom Software Inc — how do they compare? Moderna, Inc. trades at $59.72 (market cap $23.60B), while Paycom Software Inc trades at $144.05 (market cap $6.98B). The key difference: Moderna, Inc. is far larger — about 3.4× Paycom Software Inc's market cap, and Paycom Software Inc pays a 1% dividend while Moderna, Inc. pays none. Which is the better fit depends on your goals.
| MRNA | PAYC | |
|---|---|---|
Market Cap | $23.60B | $6.98B |
Sector | Health | Technology |
52-Week High | $81.80 | $238.80 |
52-Week Low | $22.36 | $113.59 |
Enterprise Value | $19.70B | $7.59B |
Dividend Yield | — | 1% |
Trailing returns across standard periods
Latest headlines on both assets
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →Paycom is a fast-growing provider of payroll and human capital management, or HCM, software primarily targeting clients with 50-10,000 employees in the United States. Paycom was established in 1998 and services about 18,000 clients as of 2021, based on parent company grouping. Alongside its core payroll software, Paycom offers various HCM add-on modules, including time and attendance, talent management, and benefits administration.
Read more on PAYC →